You are here

Journal > Clinical Medicine
Kidney Cancer

Kidney Cancer

Published in Association with Kidney Cancer
eISSN: 24684570 | ISSN: 24684562
Download flyer Recommend to Library

Kidney Cancer is an international multidisciplinary journal to facilitate progress in understanding the epidemiology/etiology, genetics, molecular correlates, pathogenesis, pharmacology, ethics, patient advocacy and survivorship, diagnosis and treatment of tumors of the kidney. The journal publishes research reports, reviews, short communications, and letters-to-the-editor.

The journal is dedicated to providing an open forum for original research in basic science, translational research and clinical medicine that will expedite our fundamental understanding and improve treatment of tumors of the kidney.

Kidney Cancer is an international multidisciplinary journal to facilitate progress in understanding the epidemiology/etiology, genetics, molecular correlates, pathogenesis, pathobiology, and pharmacology of tumors of the kidney with the objective of improving diagnosis, treatment, and survivorship in patients. The journal is directed primarily at researchers and clinicians working on these areas, with some content aimed at patients/patient advocates with these conditions. With this objective in mind, the journal publishes original research reports, systematic and regular reviews, short communications, and letters-to-the-editor in basic science, translational research and clinical medicine. The journal is committed to the highest ethical standards and best practices, and prospective authors are encouraged to consult the relevant author instructions and policies on the website at the time of submission as these are updated regularly to reflect changing guidelines.

Editors-in-Chief
Peter Mulders Radboud UMC, Netherlands
Primo N. Lara Davis Comprehensive Cancer Center, USA
Associate Editor/Social media Editor
Neeraj Agarwal Huntsman Cancer Institute, USA
Associate Editors
Laurence Albiges Université Paris Saclay, France
Axel Bex The Netherlands Cancer Institute, Netherlands
Viktor Grunwald University Hospital Essen, Germany
Shilpa Gupta Cleveland Clinic, USA
Eric Jonasch The University of Texas MD Anderson Cancer Center, USA
Bradley C. Leibovich Mayo Clinic, USA
Egbert Oosterwijk Radboud UMC, Netherlands
Javier Puente Hospital Clinico Universitario San Carlos, Spain
Manuela Schmidinger Medical University of Vienna, Austria
Sandy Srinivas Stanford University, USA
Associate Editor/Editor for reviews
Enrique Grande MD Anderson Cancer Center Madrid, Spain
Associate Editor for Reviews
Sumanta Pal City of Hope, USA
Editor of Clinical Trials Corner
Mamta Parikh UC Davis Comprehensive Cancer Center, USA
Editorial Board Members
Hideyuki Akaza University of Tokyo, Japan
Stephanie A. Berg Dana-Farber Cancer Institute, USA
Cristiane Decat Bergerot Centro de Cancer de Brasilia, Brazil
Georg A. Bjarnason Sunnybrook Odette Cancer Center, Canada
Maria T. Bourlon Instituto Nacional de Ciencias Médicas y Nutrición Salvador, Mexico
James Brugarolas University of Texas Southwestern Medical Center, USA
Ronald M. Bukowski Cleveland Clinic Foundation, USA
Steven C. Campbell Cleveland Clinic, USA
Tony K. Choueiri Dana-Farber Cancer Institute, USA
Marc Dall'era UC Davis Comprehensive Cancer Center, USA
Tanya B. Dorff City of Hope, USA
Janice P. Dutcher Cancer Research Foundation, USA
Minas P. Economides NYU Grossman School of Medicine, USA
Tim Eisen University of Cambridge and Roche, UK
Bernard Escudier Institut Gustave Roussy, France
Robert A. Figlin Cedars-Sinai Medical Center, USA
Thomas Flaig University of Colorado School of Medicine, USA
Jorge Garcia University Hospitals Seidman Cancer Center, USA
Dan George Duke University School of Medicine, USA
Ugo de Giorgi Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Italy
Shuchi Gulati UC Davis Comprehensive Cancer Center, USA
Rudolfo de Guzman National Kidney and Transplant Institute, Philippines
John Haanen Netherlands Cancer Institute, The Netherlands
Naomi Haas University of Pennsylvania, USA
Hans Hammers University of Texas Southwestern, USA
Michael R. Harrison Duke Cancer Institute, USA
Daniel Heng Tom Baker Cancer Center, Canada
Michelle S. Hirsch Brigham and Women's Hospital - Harvard Medical School, USA
James J. Hsieh Washington University School of Medicine, USA
Thomas Hutson US Oncology/Baylor, USA
Choung Soo Kim Asan Medical Center, South Korea
Christian Kollmannsberger BC Cancer Agency, Canada
James Larkin The Institute of Cancer Research, UK
Marston Linehan National Cancer Institute, USA
Borje Ljungberg Umea University, Sweden
Jose Mauricio Mota São Paulo State Cancer Institute, Brazil
Axel S. Merseburger University Hospital Schleswig-Holstein, Germany
Moshe C. Ornstein Cleveland Clinic, USA
Susanne Osanto Leiden University Medical Center, Netherlands
Karima Oualla Sidi Mohamed ben abdellah university, Morocco
Stephane Oudard Hôpital Européen Georges Pompidou, France
Allan J. Pantuck UCLA Institute of Urologic Oncology, USA
Camillo Porta IRCCS San Matteo University Hospital Foundation, Italy
Thomas Powles The Royal Free NHS Trust and Barts Cancer Institute, UK
Brian Rini Cleveland Clinic, USA
Paul Russo Memorial Sloan Kettering Cancer Center, USA
Christopher Ryan Oregon Health Science University, USA
Brian Shuch UCLA School of Medicine, USA
Andrey Soares Hospital Israelita Albert Einstein, Brazil
Ramaprasad Srinivasan National Cancer Institute, USA
Walter Stadler University of Chicago , USA
Mark Stein Columbia University, USA
Cora N. Sternberg San Camillo and Forlanini Hospitals, Italy
Nizar M. Tannir MD Anderson Cancer Center, USA
Yoshihiko Tomita Niigata University, Japan
Ilya Tsimafeyeu Bureau for Cancer Research (BUCARE), USA
Robert G. Uzzo Fox Chase Cancer Center, USA
Ulka Vaishampayan Rogel Cancer Center, USA
Guillermo de Velasco Hospital Universitario 12 de Octubre, Spain
Martin H. Voss Memorial Sloan Kettering Cancer Center, USA
Stenio Zequi AC Camargo Cancer Center, Brazil
Tian Zhang Harold C. Simmons Comprehensive Cancer Center, USA
Patricia Zondervan Amsterdam UMC, The Netherlands